Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Toby Coates, Georgina Irish et al.|The Lancet|2023

Cited by 214